NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
(Total Views: 217)
Posted On: 05/03/2018 7:10:38 PM
NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Obtains Additional Permits from Australian Government for Cannabis Importation
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has been granted two additional permits by the Australian Government, Department of Health, for the importation of a second shipment of cannabis plant materials for research purposes and the shipment of dried cannabis materials in accordance with the permits. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (“PACE”) at the University of Queensland, enable PACE to import cannabis plant material shipments for research purposes. The company’s Canadian licensed producer partner also obtained the mandatory Canadian permits to export their medical cannabis materials to PACE. The cannabis materials are used for PreveCeutical’s soluble gel (“Sol-gel”) drug delivery research program led by the company’s Chief Research Officer, Dr. Harendra Parekh, for testing various cannabis strains for the development and commercialization of cannabinoid-based Sol-gels.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has been granted two additional permits by the Australian Government, Department of Health, for the importation of a second shipment of cannabis plant materials for research purposes and the shipment of dried cannabis materials in accordance with the permits. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (“PACE”) at the University of Queensland, enable PACE to import cannabis plant material shipments for research purposes. The company’s Canadian licensed producer partner also obtained the mandatory Canadian permits to export their medical cannabis materials to PACE. The cannabis materials are used for PreveCeutical’s soluble gel (“Sol-gel”) drug delivery research program led by the company’s Chief Research Officer, Dr. Harendra Parekh, for testing various cannabis strains for the development and commercialization of cannabinoid-based Sol-gels.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)PreveCeutical Medical Inc. (PRVCF) Stock Research Links
Scroll down for more posts ▼